Deficient mismatch repair in uterine adenocarcinoma: Frequency, clinicopathological correlations and prognostic implications
Ege Tıp Dergisi · 09.03.2026 · 65 (1) · 33-39
DOI: 10.19161/etd.1748970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ege Tıp Dergisi, online erschienen am 09.03.2026. Verfasst von Ali Tümkaya und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Gefördert von: This study was supported by the Mustafa Kemal University Scientific Research Projects Unit under Project Number 25.TU.001.
Abstract (Originalsprache)
Aim
Endometrial cancer is the most common gynecological malignancy worldwide. The Cancer Genome Atlas (TCGA) molecular classification system has identified four distinct molecular subtypes with mutation burden and copy number alterations. Deficient mismatch repair (dMMR) is an important molecular marker that provides superior prognostic information compared with traditional histopathological features and guides the treatment strategy. This study aimed is to determine the frequency of dMMR in patients with uterine adenocarcinoma and evaluate its relationship with clinicopathological and prognostic parameters. Materials and Methods: This retrospective study analyzed 50 patients diagnosed with uterine adenocarcinoma/endometrioid carcinoma between January 2019 and November 2024. Immunohistochemical evaluation was performed using antibodies against MSH1, MSH6, PMS2, and MLH1 proteins. The patients were restaged according to the Gynecology and Obstetrics International Federation of FIGO 2023 staging system.
Results
Loss of mismatch repair (MMR) protein expression was observed in 20 patients (40%). The mean age of the participants was 59.18.5 years old. Immunohistochemical analysis revealed MSH2 loss in three patients (6%), MSH6 loss in four patients (8%), MLH1 loss in 13 patients (26%), and PMS2 loss in 17 patients (34%). Patients with dMMR were diagnosed at a younger age, had higher rates of lymphovascular invasion, and had a greater risk of metastasis (p:0,18; p:0,32; p:0,40 respectively). Conclusion: dMMR provides valuable prognostic information for endometrial cancer. Molecular classification is expected to play a pivotal role in guiding adjuvant treatment approaches and developing personalized therapeutic strategies in the future.
Förderung
- This study was supported by the Mustafa Kemal University Scientific Research Projects Unit under Project Number 25.TU.001
Zitieren
APA
Tümkaya, A., Dolapçıoğlu, K. S., Doğan, E., Beyazıt, A., & Yazırlıoğlu, C. (2026). Deficient mismatch repair in uterine adenocarcinoma: Frequency, clinicopathological correlations and prognostic implications. Ege Tıp Dergisi, 65(1), 33-39. https://doi.org/10.19161/etd.1748970
Vancouver
Tümkaya A, Dolapçıoğlu KS, Doğan E, Beyazıt A, Yazırlıoğlu C. Deficient mismatch repair in uterine adenocarcinoma: Frequency, clinicopathological correlations and prognostic implications. Ege Tıp Dergisi. 2026;65(1):33-39. doi:10.19161/etd.1748970
BibTeX
@article{Tmkaya2026,
author = {Tümkaya, Ali and Dolapçıoğlu, Kenan Serdar and Doğan, Esin and Beyazıt, Ahmet and Yazırlıoğlu, Can},
title = {Deficient mismatch repair in uterine adenocarcinoma: Frequency, clinicopathological correlations and prognostic implications},
journal = {Ege Tıp Dergisi},
year = {2026},
volume = {65},
number = {1},
pages = {33--39},
doi = {10.19161/etd.1748970}
}
EUVIMED